Human CD83-targeted chimeric antigen receptor T cells prevent and treat graft-versus-host diseaseBishwas Shrestha(Moffitt Cancer Center), Marco L. Davila(University of South Florida)Journal of Clinical InvestigationMay 21, 202010.1172/jci135754Cited by 60SaveCiteExport RISWatch citationsRelated Papers4-1BB enhancement of CAR T function requires NF-κB and TRAFs|JCI Insight|2018|147CAR T cell-driven induction of iNOS in tumor-associated macrophages promotes CAR T cell resistance in B cell lymphoma|Research Square|2025|3